ClinicalTrials.Veeva

Menu

Application of Megavoltage Imaging to Reduce Artifact After Seed Implants

W

William St Clair

Status

Completed

Conditions

Prostate Cancer

Treatments

Radiation: MVCT

Study type

Observational

Funder types

Other

Identifiers

NCT01810627
13-RAD-01

Details and patient eligibility

About

This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.

Enrollment

10 patients

Sex

Male

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male 50-80 years of age Eligible for interstitial brachytherapy implants

Exclusion criteria

Trial design

10 participants in 1 patient group

MVCT
Description:
Patients will receive an additional MVCT scan at their one month follow up visit.
Treatment:
Radiation: MVCT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems